To assess whether miR-195-5p directly targets DRD1 to result in dysfunction in patients with EH and T2DM, the putative binding site for miR-195-5p in the 3′-UTR of DRD1 was predicted using TargetScan (Figure 4E). The gene discussed is DRD1; the disease is type 2 diabetes mellitus.